Trends in antiseizure medication monotherapy for pediatric epilepsy in the United States

Abstract Objective National prescribing trends for antiseizure medication (ASM) in children with epilepsy over the past decade are unclear. Despite the 2021 SANAD II trials supporting lamotrigine and valproate for focal and generalized epilepsies, respectively, it is unknown if their use increased....

Descrizione completa

Dettagli Bibliografici

Autori principali:	Adam P. Ostendorf, Mariah Eisner, Mahmoud Abdel‐Rasoul, Stephanie M. Ahrens, Jaime D. Twanow, Howard P. Goodkin, Christopher W. Beatty
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wiley 2026-06-01
Serie:	Epilepsia Open
Soggetti:	antiseizure medication childhood epilepsy epilepsy lamotrigine levetiracetam valproic acid
Accesso online:	https://doi.org/10.1002/epi4.70273
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!